These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 33822968)

  • 1. Are resistance rates among bloodstream isolates a good proxy for other infections? Analysis from the BSAC Resistance Surveillance Programme.
    Horner C; Mushtaq S; Allen M; Longshaw C; Reynolds R; Livermore DM
    J Antimicrob Chemother; 2021 Jun; 76(7):1822-1831. PubMed ID: 33822968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial susceptibility of the pathogens of bacteraemia in the UK and Ireland 2001-2002: the BSAC Bacteraemia Resistance Surveillance Programme.
    Reynolds R; Potz N; Colman M; Williams A; Livermore D; MacGowan A;
    J Antimicrob Chemother; 2004 Jun; 53(6):1018-32. PubMed ID: 15128723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility of clinical isolates of meticillin-resistant Staphylococcus aureus and phenotypic non-extended-spectrum β-lactamase-producing Klebsiella pneumoniae to ceftaroline in Taiwan: Results from Antimicrobial Testing Leadership and Surveillance (ATLAS) in 2012-2018 and Surveillance of Multicentre Antimicrobial Resistance in Taiwan (SMART) in 2018-2019.
    Jean SS; Ko WC; Hsueh PR;
    Int J Antimicrob Agents; 2020 Jul; 56(1):106016. PubMed ID: 32422316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of pathogen spectrum and antimicrobial resistance of pathogens associated with hospital-acquired infections collected from 11 teaching hospitals in 2018].
    Li SG; Liao K; Su DH; Zhuo C; Chu YZ; Hu ZD; Xu XL; Zhang R; Liu WE; Lu BH; Zeng J; Jin Y; Wang H
    Zhonghua Yi Xue Za Zhi; 2020 Dec; 100(47):3775-3783. PubMed ID: 33379842
    [No Abstract]   [Full Text] [Related]  

  • 5. Antimicrobial resistance of pathogens causing nosocomial bloodstream infection in Hubei Province, China, from 2014 to 2016: a multicenter retrospective study.
    Tian L; Sun Z; Zhang Z
    BMC Public Health; 2018 Sep; 18(1):1121. PubMed ID: 30219056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-susceptibility trends and serotype distributions among Streptococcus pneumoniae from community-acquired respiratory tract infections and from bacteraemias in the UK and Ireland, 1999 to 2007.
    Farrell DJ; Felmingham D; Shackcloth J; Williams L; Maher K; Hope R; Livermore DM; George RC; Brick G; Martin S; Reynolds R;
    J Antimicrob Chemother; 2008 Nov; 62 Suppl 2():ii87-95. PubMed ID: 18819983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis on distribution and drug resistance of pathogen caused community-onset bloodstream infection].
    Mao S; Ge Z; Zhao H; Cao J; Xia Z
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Jan; 31(1):67-72. PubMed ID: 30707872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogen frequency and resistance patterns in Brazilian hospitals: summary of results from three years of the SENTRY Antimicrobial Surveillance Program.
    Sader HS; Gales AC; Pfaller MA; Mendes RE; Zoccoli C; Barth A; Jones RN
    Braz J Infect Dis; 2001 Aug; 5(4):200-14. PubMed ID: 11712965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of ceftaroline versus ceftobiprole against staphylococci and pneumococci in the UK and Ireland: analysis of BSAC surveillance data.
    Horner C; Mushtaq S; Livermore DM;
    J Antimicrob Chemother; 2020 Nov; 75(11):3239-3243. PubMed ID: 32728710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survey, laboratory and statistical methods for the BSAC Resistance Surveillance Programmes.
    Reynolds R; Hope R; Williams L;
    J Antimicrob Chemother; 2008 Nov; 62 Suppl 2():ii15-28. PubMed ID: 18819976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of BSAC agar dilution and NCCLS broth microdilution MIC methods for in vitro susceptibility testing of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: the BSAC Respiratory Resistance Surveillance Programme.
    Reynolds R; Shackcloth J; Felmingham D; MacGowan A;
    J Antimicrob Chemother; 2003 Dec; 52(6):925-30. PubMed ID: 14585864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of Drug-Resistant Bacteria in a General Hospital, China, 2011-2016.
    Mao T; Zhai H; Duan G; Yang H
    Pol J Microbiol; 2019; 68(2):225-232. PubMed ID: 31250593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of etiologic agents and antibiotic resistance in children with acute lower respiratory tract infection in Wenzhou City].
    Dong L; Zhou XC; Chen XF; Yang JH; Lin J; Zhang HL; Cai XH; Luo YC; Zhang ZX; Li CC
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Oct; 8(5):369-72. PubMed ID: 17052392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of ceftolozane/tazobactam against surveillance and 'problem' Enterobacteriaceae, Pseudomonas aeruginosa and non-fermenters from the British Isles.
    Livermore DM; Mushtaq S; Meunier D; Hopkins KL; Hill R; Adkin R; Chaudhry A; Pike R; Staves P; Woodford N;
    J Antimicrob Chemother; 2017 Aug; 72(8):2278-2289. PubMed ID: 28520867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection].
    Gong YL; Yang ZC; Yin SP; Liu MX; Zhang C; Luo XQ; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):529-35. PubMed ID: 27647068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in antimicrobial resistance and empiric antibiotic therapy of bloodstream infections at a general hospital in Mid-Norway: a prospective observational study.
    Mehl A; Åsvold BO; Kümmel A; Lydersen S; Paulsen J; Haugan I; Solligård E; Damås JK; Harthug S; Edna TH
    BMC Infect Dis; 2017 Feb; 17(1):116. PubMed ID: 28148226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1997)].
    Ikemoto H; Ito C; Yoshida T; Watanabe K; Mori T; Ohno I; Okada S; Igari J; Arakawa M; Igarashi K; Oguri T; Okada M; Ozaki K; Terai T; Aoki N; Inoue H; Nakadate T; Kitamura N; Sekine O; Suzuki Y; Ando M; Suga M; Sato K; Nakata K; Kusano N
    Jpn J Antibiot; 1999 May; 52(5):353-97. PubMed ID: 10480048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].
    Gür D; Gülay Z; Akan OA; Aktaş Z; Kayacan CB; Cakici O; Eraç B; Gültekin M; Oğünç D; Söyletir G; Unal N; Uysal S
    Mikrobiyol Bul; 2008 Oct; 42(4):537-44. PubMed ID: 19149074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial susceptibility of lower respiratory tract pathogens in Great Britain and Ireland 1999-2001 related to demographic and geographical factors: the BSAC Respiratory Resistance Surveillance Programme.
    Reynolds R; Shackcloth J; Felmingham D; MacGowan A;
    J Antimicrob Chemother; 2003 Dec; 52(6):931-43. PubMed ID: 14585865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial susceptibility of community-acquired respiratory tract pathogens in the UK during 2002/3 determined locally and centrally by BSAC methods.
    Morrissey I; Robbins M; Viljoen L; Brown DF
    J Antimicrob Chemother; 2005 Feb; 55(2):200-8. PubMed ID: 15649996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.